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Abstract
Background: In our study we compared the Ringer solution, which is the standard prime solution
of our department, with the HES (Hydroxyethyl starch) 130-0.4 solution, which can be a potential
alternative prime solution with an indispensable material for the cardio-pulmonary bypass
applications.
Methods:  140 patients undergoing to CABG (Coronary Artery Bypass Graft surgery) were
electively enrolled to the study. 1500 ml Ringer solution + 200 ml mannitol + 60 ml sodium
bicarbonate + 150 U/kg heparin was used as a prime solution to start cardiopulmonary by-pass in
70 patients which was defined as group 1. On the other hand, 1500 ml HES 130 - 0.4 + 200 ml
mannitol + 60 ml sodium bicarbonate + 150 U/kg heparin was used as a prime solution in 70
patients in group 2.
Results:  INR (International Normalized Ratio), urea levels and blood platelet counts were
significantly different between the groups. INR level was higher in group 1, while blood urea and
creatinine levels and platelet count were higher in group 2 at the end of the 12th and 24nd hours
postoperatively (p = 0.001).
In this study, it was shown that the usage of HES 130-0.4 as a prime solution did not have negative
effect on postoperative INR level, platelet count, the need for transfusion and the amount of
drainage, despite the negative opinions that similar solutions caused coagulation disorders. Another
interesting result of the study was that blood platelet count at 24th hour was statistically
significantly higher in group 2 (p = 0.001).
Conclusion: HES 130-0.4 solution is an alternative colloidal solution which can be used as the
prime solution or as a mixture with the crystalloids in cardio-pulmonary bypass applications.
Introduction
The heart-lung machine and the corresponding lines must
be prepared before beginning the cardiopulmonary
bypass procedure. To fill the venous reservoir and the
lines with fluid and to sweep away the air particles in the
lines from the system, approximately 1500–2000 ml fluid
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is needed. Balanced electrolyte solutions, starch solutions,
gelatin or mixtures of these solutions with predetermined
ratios are used [1].
Prime solutions are solutions which are used to prepare
the extracorporeal perfusion line in cardiopulmonary
bypass applications. It is prepared with balanced electro-
lyte solutions with pH and ionic distribution similar to
those of the plasma, and sometimes starch solutions,
which generally do not contain erythrocytes, are added. In
adults, the amount of prime solution is approximately
two liters. Blood is not used in prime solutions, except for
those used in anemic patients or the infants. Initial expe-
riences with prime solutions which were prepared only
with blood were unsuccessful and caused homologous
blood syndrome characterized with accumulation of
blood in splenic bed and a shock scene [1-4].
30% reduction in the renal blood flow accompanies the
renal vascular resistance during the cardiopulmonary
bypass. Ischemia caused by this condition disturbs the
glomerular and tubular functions. Hemodilution has con-
siderable beneficial effects on this situation. It enhances
renal blood and plasma flow, free water and creatine
clearance, glomerular filtration and the urine volume. It
causes significant restoration in the blood flow of renal
outer cortex [4].
Disadvantage of the haemodilution is that it reduces the
intravascular osmotic pressure and subsequently, intersti-
tial edema develops. The excessive expansion of the inter-
stitial fluid can have some drawbacks. The foremost
drawbacks are the disturbance of the lymphatic drainage
and the increase of the interstitial fluid volume. Conse-
quently, malfunctioning of many organs, especially lungs,
decrease in pulmonary compliance, hypoxia, peripheral
edema, edema in muscles and gastrointestinal system and
disturbance of the tissue oxygenation can occur [1].
This study is aimed to evaluate the effects of the excessive
expansion of the interstitial fluid through administering
the colloidal HES 130-0,4 instead of the classic method of
crystalloid Ringer solution as the prime solution and its
leading to interstitial edema and to interrogate the con-
cepts of the increase in bleeding tendency by utilizing sim-
ilar starch solutions and the unfavorable effects on renal
functions.
Methods
140 patients have been studied, who were subjected to
elective CPB interventions at our Department between
February and December 2006. Written informed consent
for participation was obtained, and the hospital ethics
committee approved the protocol.
Patients with renal insufficiency preoperatively were
excluded from this study. The study of 140 subjects with
no demographic differences was arranged by separating
them as Group 1 consisting of 70 subjects (Ringer solu-
tion) and Group 2 consisting of 70 subjects (HES 130-
0.4).
To begin the cardiopulmonary bypasses on 70 subjects of
Group 1, 1500 ml Ringer solution + 200 ml mannitol + 60
ml sodium bicarbonate + 150 IU/kg heparin was used as
the prime solution. On the other hand, to begin the cardi-
opulmonary bypasses on 70 subjects of Group 2, 1500 ml
HES 130-0,4 (Voluven®; Fresenius Kabi Deutschland
GmbH, Bad Homburg, Germany) + 200 ml mannitol + 60
ml sodium bicarbonate + 150 IU/kg heparin was used as
the prime solution.
Subjects were introduced to the cardiopulmonary bypass
by applying 2.2 l/min/m2 total systemic blood flow at
moderate hypothermia of 26–31°C. The hematocrite
value of the subjects was kept at 20–25 during the process
of cardiopulmonary bypass.
To ensure standardization between the groups, subjects
were classified according to age, sex, cross-clamp time,
cardiopulmonary bypass duration, coronary bypass
number, diabetes, chronic obstructive pulmonary disease,
hypertension, hypercholesterolemia, preoperative coro-
nary lesions, executed coronary bypass number and LIMA
(Left Internal Mammary Artery) usage. In the morning of
the operation day, 12 derivation electrocardiograms of the
subjects were executed.
Surgical procedure
All patients underwent standard median sternotomy. Car-
diopulmonary bypass was introduced by arterial cannula-
tion from the ascending aorta and by two stage venous
cannulation from the auricle of the right atrium. Cardio-
plegia cannula was positioned into the root of the aorta
and cardioplegia was given to all the patients through
antegrade way.
The prepared LIMA graft was anastomized in all patients
to the descending left anterior coronary artery (LAD).
Membrane oxygenator was used in all patients. Hemat-
ocrite was kept at 20%–25% throughout the CPB. Pump
flow of 2–2.2 l/min/m2 and nonpulsatile and median
arterial pressure through the cross-clamp was kept at 50–
60 mmHg. Following the cross clamp, the warming proce-
dure was continued until the bladder temperature reached
the 36°C.
At the 12th and 24th hours following the operation,
hematocrite, hemoglobin, platelet counts, INR, SGOT,
SGPT, urea, creatinine, sodium, potassium, chloride, andJournal of Cardiothoracic Surgery 2008, 3:45 http://www.cardiothoracicsurgery.org/content/3/1/45
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calcium levels were measured in all patients and medians
in the two groups and statistical analysis were evaluated.
Medians in two groups and statistical analysis of the
amount of the used prime solution, the amount of the
fluid added to the pump during the CPB, net balance at
the pump output, postoperative drainage, the amounts of
postoperative blood and FFP (fresh frozen plasma) trans-
fusion, extubation time, the duration of intensive care and
discharge time were evaluated.
At the 72nd hour postoperatively, the creatine clearances
of all the subjects were obtained and their statistical anal-
ysis were evaluated.
Statistical Method
For the analysis of the demographic, preoperative, opera-
tive, and postoperative data and the results of each group
with the method of median +/- t standard deviation and
with the utilization of SPSS 11.0 statistics software to get
the categorical data X2 (chi-square) and to get the multiple
variables, the One-Way Anova and the Independent-Sam-
ples-T Test methods were utilized. Values lower than 0.05
for p value were considered as significant.
Results
There is no significant difference between the risk factors
including the demographic and preoperative specifica-
tions of both groups (Table 1, Table 2).
Median data and statistical analysis of the parameters
which were compared at the 12th and 24th hours postop-
eratively are documented in Table 3 and 4.
There were no significant difference regarding the hemat-
ocrite, platelet, SGOT, SGPT, creatine, sodium, potassium,
chloride and calcium values at postoperative 24th hour
between two groups. However, there is a significant differ-
ence regarding the INR, urea and creatine values at post-
operative 24th hour (p = 0.001). The INR values of Group
1 were found to be higher at postoperative 24th hour. On
the contrary, platelet count, serum urea and creatinine val-
ues were higher in Group 2.
Consequently, it can be suggested that the utilization of
HES 130 - 0.4 as the prime solution has a negative effect
on renal functions. Although the serum urea and creatine
values were higher than the Ringer group, they were still
within the normal range and it was demonstrated that
they do not cause any serious renal damage and renal
insufficiency. On the other hand, HES 130-04 solution
has to be utilized very carefully on subjects with disturbed
renal function and on borderline patients, taking into
account the benefit/harm relationship.
Some operative and postoperative data are given in Table
5. No significant difference could be established between
the postoperative blood and FFP utilization, postopera-
Table 1: Demographic Specifications.
Group-1 Group-2 P value
Age 58 ± 7 56 ± 8 NS
Sex M/F 60/10 60/10 NS
Height (cm) 168 ± 8 167 ± 8 NS
Weight (kg) 78 ± 9 75 ± 11 NS
BSA 1.88 ± 1.2 1.85 ± 1.4 NS
Diabetes 20(%28.5) 22(%31.4) NS
Hypercholesterolemia 20 (%28.5) 20 (%28.5) NS
COPD 4(%4) 4(%4) NS
Hypertension 30(%42.8) 30 (%42.8) NS
Sick vessel number 3(%100) 3(%100) NS
Graft number 3.4 ± 0.62 3.48 ± 0.58 NS
LİMA usage 70 (%100) 70 (%100) NS
(COPD: Chronic Obstructive Pulmonary Disease. BSA: Body Surface 
Area. LİMA: Left internal mammarian artery. NS: Not significant (p > 
0.05)).
Table 2: Preoperative Specifications.
Group 1 Group 2 P value
Hematocrite(%) 42 ± 3 41 ± 4 NS
Hemoglobin(gr/dL) 14 ± 1 14 ± 1 NS
Platelet(103/μl) 240 ± 80 272 ± 60 NS
INR 1.07 ± 0.12 1.04 ± 0.15 NS
SGOT(U/L) 20 ± 2 26 ± 4 NS
SGPT(U/L) 44 ± 10 43 ± 8 NS
Urea(mg/dL) 37 ± 10 38 ± 11 NS
Creatine(mg/dL) 1 ± 0.2 1.1 ± 0.1 NS
Creatinine clearance 76 ± 8 82 ± 6 NS
Na (meq/L) 139 ± 8 140 ± 4 NS
K (meq/L) 4.6 ± 0.2 4.4 ± 0.3 NS
Cl (meq/L) 101 ± 5 102 ± 4 NS
Ca (mg/dl) 8.8 ± 0.5 9.1 ± 0.1 NS
NS: Not significant (p > 0.05).
Table 3: Data of postoperative 12th hours.
Group 1 Group 2 P value
Hematocrite(%) 29 ± 4 29 ± 3.5 NS
Hemoglobin(gr/dL) 10 ± 1 10 ± 1 NS
Platelet(103/μl) 155 ± 25 175 ± 30 NS
INR 1.39 ± 15 1.05 ± 9 0.0001*
SGOT(U/L) 73 ± 16 85 ± 20 NS
SGPT(U/L) 40 ± 15 42 ± 18 NS
Urea(mg/dL) 30 ± 12 41 ± 15 0.0001*
Creatine(mg/dL) 1.1 ± 0.3 1.3 ± 0.3 NS
Na (meq/L) 137 ± 6 138 ± 6 NS
K (meq/L) 4.1 ± 0.2 4.1 ± 0.3 NS
Cl (meq/L) 103 ± 5 102 ± 4 NS
Ca (mg/dl) 7.4 ± 0.5 7.4 ± 0.6 NS
NS: Not significant (p > 0.05).Journal of Cardiothoracic Surgery 2008, 3:45 http://www.cardiothoracicsurgery.org/content/3/1/45
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tive drainage, extubation time, intensive care duration
and discharge time.
There is a significant difference in the used prime solution
volume during the CPB regarding the fluid volume added
to the pump and the net balance at the pump outlet (p =
0.001).
The prime solution volume and the net balance at the
pump outlet of the group of HES 130-0.4 were signifi-
cantly lower. Approximately 1360 ml of fluid was added
to the pump of the patients with Ringer solution group
during the CPB. In the HES 130-0.4 group, there was no
need for feeding any additional fluid to the pump.
Although the fluid loading and the interstitial edema were
significantly lower in the HES 130-04 group, there was no
statistically significant difference regarding to the extuba-
tion, intensive care stay and discharge time, which can be
considered as criteria basic for the evaluation of the sub-
jects. Nevertheless, it is evident that the medians of these
intervals are shorter than that of the Ringer solution
group. We thought that, by comparing groups with more
subjects, a statistically significant conclusion can be
reached for these parameters.
No significant difference could be established regarding
the creatine clearance of both groups at the 72nd hour.
Nevertheless, by scrutinizing the creatine clearance of
both groups after CPB, it can be seen that there is a
decrease in the median values of both groups; this
decrease is more marked for the HES 130-0.4 group. By
comparing the creatine clearance of both groups at the
72nd hour, it can be seen that the creatine clearance is
numerically lower for the HES 130-0.4 group. As we
emphasized while evaluating the former results, it can be
thought that the HES 130-0.4 solution gives more adverse
effect on the renal functions.
With respect to the postoperative INR, platelet count,
transfusion need and drainage amount, it can be seen that
there is no increase in the bleeding tendency and no dis-
turbance of the coagulation functions with the usage of
HES 130-0.4 solution as the prime solution, as it was
before with similar starch solutions. Interestingly, it was
found out that the platelet count at the 24th hour postop-
eratively was statistically significantly higher for the HES
130-0.4 group.
Discussion
The Ringer solution which is used as the prime solution
during CPB causes edema through decreasing the colloi-
dal osmotic pressure. As a result of edema, which affects
many tissues, various organ dysfunctions occur after CPB.
It is still disputed whether to use crystalloid or colloidal
Table 4: Postoperative data at the 24th hour.
Group 1 Group 2 P value
Hematocrite(%) 28 ± 4 29 ± 3.5 NS
Hemoglobin(gr/dL) 9 ± 1.5 10 ± 1.3 NS
Platelet(103/μl) 148 ± 36 189 ± 66 0.001*
INR 1.38 ± 0.19 1.12 ± 0.09 0.001*
SGOT(U/L) 71 ± 13 99 ± 17 NS
SGPT(U/L) 43 ± 11 44 ± 12 NS
Urea(mg/dL) 32 ± 10.3 46 ± 12.3 0.001*
Creatine(mg/dL) 1,1 ± 0.22 1,4 ± 0.24 0.001*
Na (meq/L) 133 ± 6 135 ± 8 NS
K (meq/L) 4 ± 0.9 4.1 ± 0.8 NS
Cl (meq/L) 100 ± 6 101 ± 6 NS
Ca (mg/dl) 7.5 ± 1.2 7.5 ± 1.3 NS
SGOT; Serum glutamic oxaloacetic transaminase, SGPT; Serum 
glutamic pyruvic transaminase. NS: Not significant (p > 0.05).
Table 5: Operative and postoperative data.
Group 1 Group 2 P value
ACT (A) value 128 ± 18 132 ± 16 NS
ACT (after protamine) 138 ± 24 143 ± 32 NS
Aortic cross clamp duration (min) 85 ± 11 90 ± 13 NS
Cardiopulmonary bypass duration (min) 100 ± 23 108 ± 25 NS
Prime solution amount (ml) 1500 1500 NS
Fluid added to the pump during CPB (ml) 1360 ± 360 0 0.0001*
Net balance at the pump outlet (ml) 1515 ± 270 590 ± 100 0.0001*
Postoperative blood transfusion (units) 2 2 NS
Postoperative FFP transfusion (units) 2 2 NS
Postoperative drainage (ml) 460 ± 140 430 ± 150 NS
Extubation time (hour) 10 ± 4 9 ± 4,5 NS
Intensive care stay (hour) 47 ± 12 45 ± 10 NS
Creatine clearance at postoperative 72nd hour 68 ± 15 64 ± 15 NS
Discharge time (days) 9 ± 3 8 ± 3 NS
ACT: Active coagulation time; CPB: Cardiopulmonary bypass; FFP: Fresh frozen plasma; NS: Not significant (p > 0.05).Journal of Cardiothoracic Surgery 2008, 3:45 http://www.cardiothoracicsurgery.org/content/3/1/45
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solution as the prime solution. Many studies are both for
and against one or the other [2].
HES controls the transition of the fluid into the intersti-
tium through CPB. Laubenthal and Messmer were able to
demonstrate by their study that the HES colloidal solution
possesses a higher oncotic effect than albumin. Colloidal
particles show their effect through the semipermeable
membrane of the capillaries. This effect diminishes the
transition of the fluid to the interstitium [3].
In our study, it was found out that the net balance was
+1515 ml for the Ringer group and +590 ml for the HES
group. This result has shown that the net balance was sta-
tistically significantly lowered down for the HES group.
Extubation time was determined as approximately 232
minutes for the Ringer group and 173 minutes for the HES
group. It was determined that maximum edema forma-
tion was in the group where only Ringer was used as the
prime solution. They found out that there was a signifi-
cant shortening of the ventilation time in favor of the HES
group [2].
In our study, no statistically significant difference could be
established between the two groups regarding the extuba-
tion times, intensive care duration and discharge time.
Nevertheless, it was established that the mean values of
these criteria were shorter in the HES group. By compari-
son of groups with bore subjects, it can be possible to
establish a statistically significant result for these parame-
ters.
The potential relationship between the intraoperative
HES utilization and the postoperative bleeding is a con-
cept which is still being discussed without any undivided
opinion yet.
Complications of bleeding after open heart surgeries are
often encountered. Previous studies have shown that
0.6%–15% of the patients have to be revised because of
bleeding. In less severe cases, the bleeding has been
treated with blood transfusions and with the methods of
regulating the coagulation pattern. Clinical and economi-
cal effects of the bleeding complications after CPB are very
extensive. Consequently, attempts to reduce postoperative
bleeding are gaining importance. Two of the determined
risk factors are age and female sex.
One of the risk factors which can be manipulated is the
utilization of perioperative HES [3-7].
In the patients of HES 130-0.4, the increase in the von
Willebrand factor were more pronounced while the blood
loss and the usage of erythrocyte concentrate were less [8].
In our study, the postoperative drainage volume was
approximately 460 ml for the group of Ringer solution as
the prime solution and approximately 430 ml for the
group of HES 130-0.4; no statistical difference between
the two groups could be established.
The increase of renal vascular resistance during the CPB is
accompanied by the 30% decrease of the renal blood
flow. The resulting ischemia disturbs the glomerular and
tubular functions.
Besides, it is well known that diuretics, aprotinine, preop-
erative opaque material intake and many medications
used during the CPB have unfavorable effects on the renal
functions. When haemodilution is not used, CPB will
decrease the free water and creatinine clearance in con-
junction with urine volume. Haemodilution has consider-
able benefits on this subject. It increases the renal blood
and plasma flow, free water, creatinine clearance, glomer-
ular filtration rate and urine volume; it particularly causes
considerable improvement on the blood flow of renal
outer cortex [4].
Some case reports and clinical information claim that the
utilization of hydroxyethyl starch can destroy the renal
functions, but this assertion was investigated only in a
small number of studies and the results are controversial.
In their study of patients who underwent CPB, Winkel-
mayer et al. have determined that HES utilization was
related with the independent decrease in the glomerular
filtration velocity at the 3rd and 5th days after surgery.
They pointed out that the intraoperative HES utilization
in patients of coronary artery bypass surgery will cause a
slight disturbance of renal functions [9].
In another study of Boldt et al. of patients older than 70
years, gelatin was compared with HES 130-0.4 and they
could not establish any difference between the two vol-
ume replacement applications regarding the renal integ-
rity [10].
In the study of Maha et al. for the determination of opti-
mal amount of HES to use as the prime solution in CPB
patients, mean urine volume was 2003 ml in the Ringer
group and 1710 ml in the HES group. Although there was
a decrease in the HES group, there was no statistically sig-
nificant difference between the two groups [2].
In our study, urea values at the 12th hour postoperatively
were 30 mg/dl for the Ringer group and 41 mg/dl for thePublish with BioMed Central    and   every 
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HES group. These results are statistically significant and
show that the urea values are higher in the HES group.
Creatine values at the 12th hour postoperatively were 1.1
mg/dl for the Ringer and 1.3 mg/dl for the HES group.
There is no statistically significant difference between the
two groups.
Urea value at the 24th hour was mean 32 ± 10.3 mg/dl for
the Ringer group and mean 46 ± 12.3 mg/dl for the HES
group. Creatine value was 1.1 mg/dl for the Ringer group
and 1.4 mg/dl for the HES group. These values show the
statistically significant difference between the two groups.
Creatinine clearance which was investigated at the post-
operative 72nd hour was mean 68 ± 14 in the Ringer
group and 64 ± 14 in the HES group. By comparison, it
comes out that there is no statistical difference between
the two groups.
Consequently, it can be suggested that the utilization of
HES 130-0.4 as the prime solution has unfavorable effects
on the renal functions. Although the serum urea and cre-
atine values were higher than those of the Ringer group,
these values were within the normal range and it was seen
that they did not cause any serious renal damage and renal
insufficiency.
In conclusion, HES 130-0.4 solution is an alternative col-
loidal solution which can be used as the prime solution in
cardio-pulmonary bypass applications.
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